CONNECTING CLIENTS + PAYERS

policy

Health Policy spans our work with pharmaceuticals, medical devices and diagnostics from both a funding and access perspective. WestPAR has substantial experience in working collaboratively with governments in Western Canada to shift and reconfigure Policy to meet the emerging needs and realities of our evolving healthcare system.

payers

Private and Provincial funding markets for pharmaceuticals, medical devices and diagnostics continue to rapidly evolve in response to concerns over balancing long-term sustainability, fiscal responsibility, therapeutic gaps, innovation, and increasing therapeutic options in rare diseases. WestPAR has the understanding, knowledge and skill set required to help you achieve your goals in Western Canada.

industry

Innovation often creates new system challenges and barriers to access and funding. Having an experienced partner is critical to developing the appropriate strategy, acquiring guidance, and building collaborative consensus with government decision and policy makers.

HEALTH POLICY
PUBLIC PAYERS
PRIVATE PAYERS
HOSPITALS
PHARMACEUTICALS
MEDICAL DEVICES
DIAGNOSTICS

EXPERTISE

strategy

Collaborative Approach Western Public Payer National Private Payer Western Lead pCPA

research

Market Research Clinical / Therapeutic Research Environment Scans Influence Mapping.

advocacy

Public + Private Payer Meetings Provincial Ministries + MLAs Patient Group Engagement Comprehensive Campaigns

negotiations

Western Public Payers PLAs National Private Payer PLAs Western Lead pCPA Western Provincial LOls

submissions

Western Provincial Public Payers National Private Payers Hospital

CAPABILITIES

western canada
•Reimbursement and Access    Strategy
•Provincial Submissions
•Hospital Formulary Submissions
•Budget Impact Analysis (BIA)    Modeling
• Payer Negotiations
• Payer Tours and Meetings
national

• pCPA Engagement Strategy Western Perspective
• pCPA Negotiations with Western Lead Provinces
• Budget Impact Analysis (BIA) Modelling
• pCPA specific BIA Modeling
• Market Impact Modeling
• Environmental Scans

Strategic partner collaboration

•PMPRB Pricing Strategy
•CDR Submissions (CAT I + II)
pCPA Strategy Negotiations
•Pharmacoeconomic Studies + Analysis
•Ontario + Quebec Specific Access, Funding and Policy Issues